SCHEMBL3882391

SCHEMBL3882391

COC(=O)CCc1ccc(OCc2cccc3ccccc23)c(-c2ccc3[nH]ccc3c2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 2/20 0.42
AKR1B1 P15121 1/20 0.42
ENPP2 Q13822 1/20 0.42
BCL2L1 Q07817 1/20 0.41
MCL1 Q07820 1/20 0.40
FDPS P14324 1/20 0.40
PTPN1 P18031 2/20 0.39
CCNC P24863 1/20 0.39
CDK8 P49336 1/20 0.39
BRD4 O60885 1/20 0.38
KMT2A Q03164 2/20 0.38
MEN1 O00255 1/20 0.38
EPHX1 P07099 1/20 0.38
CYP2D6 P10635 1/20 0.38
EPHX2 P34913 1/20 0.38
PARP15 Q460N3 1/20 0.38
PARP10 Q53GL7 1/20 0.38
MAP3K11 Q16584 1/20 0.37
SMPD1 P17405 1/20 0.37
FFAR4 Q5NUL3 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3885602 0.90 FFAR1 (0.54) FFAR1AKR1B1ENPP2BCL2L1MCL1
SCHEMBL3881742 0.89 HDAC1 (0.43) FFAR1ENPP2PTPN1CCNCCDK8
SCHEMBL3886299 0.89 FFAR4 (0.46) FFAR1ENPP2PTPN1BRD4FFAR4
SCHEMBL3887506 0.89 ENPP2 (0.43) FFAR1ENPP2PTPN1CCNCCDK8
SCHEMBL3881437 0.89 FFAR4 (0.49) FFAR1ENPP2PTPN1CCNCCDK8
SCHEMBL3882666 0.89 FFAR1 (0.49) FFAR1ENPP2MCL1PTPN1CCNC
SCHEMBL3881998 0.87 ENPP2 (0.53) FFAR1ENPP2MCL1PTPN1BRD4
SCHEMBL3882400 0.87 FFAR1 (0.41) FFAR1ENPP2MCL1PTPN1CCNC
SCHEMBL3883797 0.86 CCNC (0.46) ENPP2PTPN1CCNCCDK8BRD4
SCHEMBL3881133 0.86 ENPP2 (0.53) FFAR1ENPP2PTPN1BRD4EPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1477472-B1 SUBSTITUTED PHENYLALKANOIC ACID DERIVATIVE AND USE THEREOF ASAHI KASEI PHARMA CORP (JP) 2009-01-14 EP claimed
US-6867320-B2 Substituted phenylalkanoic acid derivatives and use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2005-03-15 US claimed
EP-1477472-A1 SUBSTITUTED PHENYLALKANOIC ACID DERIVATIVE AND USE THEREOF Asahi Kasei Pharma Corporation (JP) 2004-11-17 EP claimed
US-20040044258-A1 Substituted phenylalkanoic acid derivatives and use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2004-03-04 US claimed
EP-1477472-B1 SUBSTITUTED PHENYLALKANOIC ACID DERIVATIVE AND USE THEREOF ASAHI KASEI PHARMA CORP (JP) 2009-01-14 EP disclosed
US-6867320-B2 Substituted phenylalkanoic acid derivatives and use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2005-03-15 US disclosed
EP-1477472-A1 SUBSTITUTED PHENYLALKANOIC ACID DERIVATIVE AND USE THEREOF Asahi Kasei Pharma Corporation (JP) 2004-11-17 EP disclosed
US-20040044258-A1 Substituted phenylalkanoic acid derivatives and use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2004-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040044258-A1 Substituted phenylalkanoic acid derivatives and use thereof PTGER1, CYSLTR1, PTGS1 FFAR1 13/4885AKR1B1 86/4885ENPP2 333/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.